www.fdanews.com/articles/157331-bristol-myers-squibb-revenue-falls-as-expected

Bristol-Myers Squibb Revenue Falls As Expected

July 25, 2013

Bristol-Myers Squibb sales fell 9 percent after the loss of patents on Avapro and Plavix.
The Pharma Letter